definitive radiation

definitive radiation

Radiation oncology Administration of radiation as a sole or 1º therapy, usually for CA, with curative intent; DR doses average 40-50 Gy/4-5000 rads. See Radiation therapy.
References in periodicals archive ?
Garg et al., "ACR appropriateness criteria[R] retreatment of recurrent head and neck cancer after prior definitive radiation: Expert panel on radiation oncology-head and neck cancer," International Journal of Radiation Oncology * Biology * Physics, vol.
Shedden et al., "Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy," International Journal of Radiation Oncology Biology Physics, vol.
Pneumocephalus after radiation alone is rare and has been described in cases of definitive radiation for treatment of nasopharyngeal carcinoma.
Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules.
Protection against nuclear or radiological attack has motivated the search for more definitive radiation detection and identification technologies.
A prospective clinical study provides a direct comparison between cisplatin and paclitaxel used as weekly concurrent chemotherapy with definitive radiation for locally advanced carcinoma cervix.
Definitive radiation treatment with chemotherapy is utilized as the initial treatment strategy for many advanced laryngeal cancers except those with cartilage involvement.
Management of prostate cancer recurrence after definitive radiation therapy.
Ki-67 cut-off levels of <3.5% and >7.1% were used based on retrospective validation of these values in predicting outcomes following definitive radiation treatment in patients treated on two separate RTOG trials [15, 16].
Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy.
These include adjuvant therapy for resected squamous cell carcinoma of the head and neck (new); local-regional therapy for resectable oropharyngeal squamous cell carcinomas; and retreatment of recurrent head and neck cancer after prior definitive radiation.
"This study, along with other emerging studies, strongly suggests that statin use improves outcomes in patients treated with definitive radiation therapy," added Zelefsky.